Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan;36(1):5-15.
doi: 10.1007/s40620-022-01369-y. Epub 2022 Jun 27.

Renal sarcoidosis

Affiliations
Review

Renal sarcoidosis

Marta Calatroni et al. J Nephrol. 2023 Jan.

Abstract

Sarcoidosis is a systemic inflammatory disease of unknown etiology. The pathogenesis rests on an aberrant T cell response to unidentified antigens in individuals predisposed by genetic and environmental factors. Increased expression of polarized macrophages and disequilibrium between effector and regulator T cells contribute to the formation of noncaseating granulomas, that are frequently found in affected organs. The main kidney abnormalities in sarcoidosis are granulomatous interstitial nephritis (GIN) and hypercalcemia-related disorders. The clinical diagnosis is difficult. The outcome is variable, ranging from spontaneous remission to end-stage kidney disease (ESKD). Early diagnosis and prompt treatment with corticosteroids can improve the prognosis. Hypercalcemia may be responsible for acute kidney injury (AKI) caused by vasoconstriction of afferent arterioles. Complications of persistent hypercalcemia include nephrocalcinosis and renal stones. In patients with ESKD, dialysis and transplantation can offer results comparable to those observed in patients with other causes of kidney failure. Based on a review of the literature, we present an overview of the etiopathogenesis, the renal manifestations of sarcoidosis and their complications, management and prognosis.

Keywords: Acute kidney injury; End-stage kidney disease; Granulomatous interstitial nephritis; Hypercalcemia; Noncaseating granulomas; Renal sarcoidosis.

PubMed Disclaimer

References

    1. Larsson J, Graff P, Bryngelsson IL, Vihlborg P (2020) Sarcoidosis and increased risk of comorbidities and mortality in Sweden. Sarcoidosis Vasc Diffuse Lung Dis 37(2):104–135. https://doi.org/10.36141/svdld.v37i2.9142 - DOI
    1. Hena KM (2020) Sarcoidosis epidemiology: race matters. Front Immunol 11:537382. https://doi.org/10.3389/fimmu.2020.537382 - DOI
    1. Sikjær MG, Hilberg O, Ibsen R, Løkke A (2021) Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up. Respir Med 187:106548. https://doi.org/10.1016/j.rmed.2021.106548 - DOI
    1. Arkema EV, Cozier YC (2020) Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med 26(5):527–534. https://doi.org/10.1097/MCP.0000000000000715 - DOI
    1. Yoon HY, Kim HM, Kim YJ, Song JW (2018) Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir Res 19(1):158. https://doi.org/10.1186/s12931-018-0871-3 - DOI

LinkOut - more resources